Entrepreneurial pathways to impact: spinning-out your research
Hosted by Cambridge Innovation Capital in partnership with Cambridge Enterprise
Supported by Babraham Institute, Wellcome Sanger Institute, Start Codon and Deeptech Labs
In person event at the Clayton Hotel, Cambridge, on 29 September from 14.00-17.30 plus networking
The event will feature case studies, building around a ‘tasting menu’ of ideas and expertise, including sessions on Does good technology always look good, Who should you entrust managing your spin out to and Options for fundraising, culminating with an opportunity to meet the experts in person for conversation and networking.
Event highlights:
We are pleased to host this event in person at the Clayton Hotel, Station Road, Cambridge.
View and download the slides from the event
Watch some of the event highlights at the links below
Dr Andrew Williamson, Managing Partner, discusses the Cambridge ecosystem
Professor Andy Neely, Pro Vice-Chancellor for Enterprise, University of Cambridge
Fireside chat with Professor Allan Bradley, world-renowned researcher and entrepreneur and Dr Robert Tansley
Dr Rachel Oliver, Porotech
Professor Carl Rasmussen, Secondmind
Dr Steve Brierley, Riverlane
Dr Nitzan Rosenfeld, Chief Scientific Officer, Inivata
Panel session
Professor Allan Bradley, Dr Steve Brierley, Dr Nitzan Rosenfeld, Dr Rachel Oliver, Professor Carl Rasmussen and Dr Robert Tansley
Dr Iain Thomas asks, 'Does good technology always look good?'
Dr Ian Lane, Partner discusses 'who should you entrust managing your spin-out to?'
Dr Anne Horgan, Partner, discusses options for fund raising
Dr Andrew Williamson, Managing Partner, introduces key potential partners from within the Cambridge entrepreneurship ecosystem
Dr Anita Marguerie de Rotrou, Knowledge Exchange Network
Dr Robert Tansley introduces 'entrepreneurial pathways to impact: spinning-out your research'
Dr Christine Martin, Cambridge Enterprise
Dr Adrian Ibrahim, Sanger Institute
Simon Thorpe, Cambridge Angels
Derek Jones, Babraham Accelerator
Dr Jason Mellad, Start Codon
Miles Kirby, Deeptech Labs